Nanoscale arrangement of apoptotic ligands reveals a demand for a minimal lateral distance for efficient death receptor activation.
about
Molecular Occupancy of Nanodot Arrays.Rolled-up functionalized nanomembranes as three-dimensional cavities for single cell studies.Nanotechnology in drug delivery and tissue engineering: from discovery to applicationsAre different stoichiometries feasible for complexes between lymphotoxin-alpha and tumor necrosis factor receptor 1?Development of functional biomaterials with micro- and nanoscale technologies for tissue engineering and drug delivery applications.Nanolithographic control of the spatial organization of cellular adhesion receptors at the single-molecule level.Nanoscale ligand spacing influences receptor triggering in T cells and NK cellsAntagonistic TNF receptor one-specific antibody (ATROSAB): receptor binding and in vitro bioactivityProtein tethering into multiscale geometries by covalent subtractive printing.Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.Cell-surface receptor control that depends on the size of a synthetic equilateral-triangular RNA-protein complex.Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces death receptor 5 networks that are highly organized.The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.Fine tuning and efficient T cell activation with stimulatory aCD3 nanoarrays.Spatial Control of Biological Ligands on Surfaces Applied to T Cell Activation.A protein nanofiber hydrogel for sensitive immunoassays.Nanoscale Tuning of VCAM-1 Determines VLA-4-Dependent Melanoma Cell Plasticity on RGD Motifs.
P2860
Q30840635-9E24EB9A-E04F-435B-96E2-9C0830D365C7Q34046490-566BA89A-43E7-4D01-BA14-174AF0D8F87CQ34112647-5AB09BD3-0729-4CC6-85D5-0AD6610D14E2Q34262443-3416ADA6-B32F-4E8D-8421-61420921DD85Q34349709-9E824ACF-C0E0-40CB-AB92-E4AB4965F1CFQ34700615-24172A7C-11B2-420C-81E1-5E179AC11328Q34886056-2CF8864F-8139-457B-954E-77542761496FQ34973492-FF4AA854-2DAE-4527-9FEE-13D09767404CQ35090323-332A8E3B-AC71-4F37-A25F-5799805FCE46Q38659118-210EEBE3-8337-4A9C-A4A6-50F4AD628953Q41901497-CBF9AA8D-D48E-401B-B77F-B067B4638F70Q42091109-8A3E965F-7D41-4177-AABF-F7B06AE056ABQ42323234-E3C72DEF-8C77-4652-945E-ADBF579C333DQ42876926-06C95E66-BA4E-4524-8665-8DB1D62D4340Q47952339-1FC1BC81-9A45-4C31-9F5A-D98E445DA4BEQ48006485-4AA944CF-3DD4-48D1-B6AB-47592647AE64Q49989677-5FC70968-B54F-4C55-BF64-B26CCC69D9FA
P2860
Nanoscale arrangement of apoptotic ligands reveals a demand for a minimal lateral distance for efficient death receptor activation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Nanoscale arrangement of apopt ...... ent death receptor activation.
@ast
Nanoscale arrangement of apopt ...... ent death receptor activation.
@en
Nanoscale arrangement of apopt ...... ent death receptor activation.
@nl
type
label
Nanoscale arrangement of apopt ...... ent death receptor activation.
@ast
Nanoscale arrangement of apopt ...... ent death receptor activation.
@en
Nanoscale arrangement of apopt ...... ent death receptor activation.
@nl
prefLabel
Nanoscale arrangement of apopt ...... ent death receptor activation.
@ast
Nanoscale arrangement of apopt ...... ent death receptor activation.
@en
Nanoscale arrangement of apopt ...... ent death receptor activation.
@nl
P2093
P2860
P356
P1433
P1476
Nanoscale arrangement of apopt ...... ent death receptor activation.
@en
P2093
Anja Krippner-Heidenreich
Jessica Tepperink
Julia Ranzinger
Peter Scheurich
Tamas Haraszti
P2860
P304
P356
10.1021/NL902429B
P407
P577
2009-12-01T00:00:00Z